Skip to main content
. 2024 Jun 27;240(5-6):767–777. doi: 10.1159/000539536

Fig. 4.

Fig. 4.

Proportion of patients reporting moderately/very satisfied and moderately/very dissatisfied (a) with hair growth overall, (b) with the amount of hair growth, and (c) with the quality of new hair growth at weeks 24 and 48. a Patients received placebo until week 24 and then were switched to active ritlecitinib treatment.